Jaeschke R, Guyatt G, Shannon H, Walter S, Cook D, Heddle N
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont.
CMAJ. 1995 Feb 1;152(3):351-7.
In the third of a series of four articles the authors show the calculation of measures of association and discuss their usefulness in clinical decision making. From the rates of death or other "events" in experimental and control groups in a clinical trial, we can calculate the relative risk (RR) of the event after the experimental treatment, expressed as a percentage of the risk without such treatment. The absolute risk reduction (ARR) is the difference in the risk of an event between the groups. The relative risk reduction is the percentage of the baseline risk (the risk of an event in the control patients) removed as a result of therapy. The odds ratio (OR), which is the measure of choice in case-control studies, gives the ratio of the odds of an event in the experimental group to those in the control group. The OR and the RR provide limited information in reporting the results of prospective trials because they do not reflect changes in the baseline risk. The ARR and the number needed to treat, which tells the clinician how many patients need to be treated to prevent one event, reflect both the baseline risk and the relative risk reduction. If the timing of events is important--to determine whether treatment extends life, for example--survival curves are used to show when events occur over time.
在系列四篇文章的第三篇中,作者展示了关联度量的计算方法,并讨论了它们在临床决策中的实用性。从临床试验中实验组和对照组的死亡或其他“事件”发生率,我们可以计算出实验性治疗后该事件的相对风险(RR),以未进行该治疗时的风险百分比表示。绝对风险降低率(ARR)是两组之间事件风险的差值。相对风险降低率是因治疗而消除的基线风险(对照组患者发生事件的风险)的百分比。比值比(OR)是病例对照研究中选用的度量指标,它给出了实验组中事件发生的比值与对照组中事件发生比值的比率。在报告前瞻性试验结果时,OR和RR提供的信息有限,因为它们没有反映基线风险的变化。ARR和需治疗人数(它告诉临床医生需要治疗多少患者才能预防一例事件)既反映了基线风险,也反映了相对风险降低率。如果事件发生的时间很重要——例如,确定治疗是否能延长生命——则使用生存曲线来显示事件随时间发生的情况。